TerminatedNCT04717024

The Nanowear Wearable Covid-19 Observational and Analysis Trend

Sponsor: Nanowear Inc.

Trial Details

Condition	Covid19
Intervention	Observational Study - no intervention
Status	Terminated
Participants	15
Est. Completion	15 Apr 2021
Last Updated	9 Apr 2026

Primary Outcome

Hosptialized patient data

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * Subject has provided informed consent * Male or female over the age of 18 years * The patient is currently hospitalized with a primary diagnosis of Covid-19 Exclusion Criteria: * Subject is unwilling or unable to wear the vest during hospitalization. * Subjects who are pregnant. * Subject is intubated or admitted to ICU * Subject has an implantable cardiac device (i.e pacemaker or internal cardioverter defibrillator)

Trial Sites

Countries

United States

View Registry Entry

Related Analysis

Terminated COVID-19 Wearable Monitoring Study Highlights Challenges in Digital Health Research During Pandemic

The terminated NanoCOAT study attempted to use wearable technology for continuous COVID-19 patient monitoring but faced implementation challenges. Early termination with only 15 participants highlights the complexities of digital health research during healthcare crises.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service